Targeted Treatment for Prostate Cancer: Clinical Trial Insights

This chapter covers a groundbreaking clinical trial for long-term prostate cancer using PSMA lutetium-177, a targeted therapy that aims to deliver radionuclide treatment directly to cancer cells. The discussion includes how listeners can find out more about the trial and access related medical facilities.